行情

OASMY

OASMY

Vivesto
OTCPK
0.197
0.000
0.00%
已收盘, 16:00 10/04 EDT
开盘
--
昨收
0.197
最高
--
最低
--
成交量
--
成交额
--
52周最高
1.223
52周最低
0.197
市值
3,540.32万
市盈率(TTM)
-5.7052
分时
5日
1月
3月
1年
5年
暂无数据
OASMY 简况
Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company dedicated to improving the lives of patients by enhancing the intravenous delivery of drugs in diseases such as cancer. Product development is based on Oasmia’s drug delivery platform which can be applied to medicines used in many therapeutic areas, to develop water soluble formulations of drugs that usually require chemical solubilizers for dissolution. The Company's approved product that is using this technology is Apealea (paclitaxel micellar). Apealea has market authorization in the European Union and several other territories for the treatment of first relapse in platinum-sensitive ovarian cancer, in combination with carboplatin. The Company is making Apealea accessible to patients through its partnership with Elevar Therapeutics, together with its existing commercial operations in the Nordic region.

微牛提供Oasmia Pharmaceutical AB(OTCPK-OASMY)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的OASMY股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易OASMY股票基本功能。